Related Experiment Video
Updated: Aug 17, 2026

A Silver Nanoparticle Method for Ameliorating Biliary Atresia Syndrome in Mice
Published on: October 13, 2018
Prevalence of hepatitis A virus infection in children with biliary atresia
Voranush Chongsrisawat1, Apiradee Theamboonlers, Yong Poovorawan
1Center of Excellence in Viral Hepatitis, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
Insights
Hepatitis A virus (HAV) infection is prevalent in children with biliary atresia (BA), particularly in older children. HAV infection may worsen liver damage in BA patients, highlighting the need for further immunization studies.
Area of Science:
- Hepatology
- Virology
- Pediatric Gastroenterology
Background:
- Biliary atresia (BA) is a serious pediatric liver disease.
- Children with BA are at risk of severe liver damage, especially if portoenterostomy fails.
- Superimposed viral infections can exacerbate liver disease in BA patients.
Purpose of the Study:
- To determine the prevalence of hepatitis A virus (HAV) infection in children with biliary atresia (BA).
- To assess the relationship between HAV seropositivity and patient age and clinical outcomes in BA.
- To evaluate the potential impact of HAV infection on liver function in children with BA.
Main Methods:
- Blood samples were collected from 77 children diagnosed with BA between May 2002 and May 2003.
- Patients had undergone portoenterostomy and attended a pediatric liver clinic.
- HAV seropositivity was determined and analyzed in relation to age and total bilirubin levels.
Main Results:
- The overall HAV seropositivity rate was not explicitly stated, but rates were 13.1% for patients <10 years and 25% for patients >=10 years.
- No statistically significant difference in HAV seropositivity was found between patients with favorable (bilirubin <=2 mg/dl) and unfavorable (bilirubin >2 mg/dl) outcomes (p = 0.6).
- Higher seropositivity rates were observed in older children with BA.
Conclusions:
- Hepatitis A virus infection is present in children with biliary atresia.
- HAV infection may pose an additional risk to liver function in BA patients, potentially leading to severe disease.
- The efficacy of HAV immunization in this vulnerable pediatric population warrants further investigation.
Abstract:
This study aimed at identifying the prevalence of hepatitis A virus (HAV) infection in children with biliary atresia (BA). Blood samples were collected from children with BA whom had undergone portoenterostomy and attended the pediatric liver clinic, King Chulalongkorn Memorial Hospital between May 2002 and May 2003. Seventy-seven patients, 45 females and 32 males, ages ranging from 0.2-19 years (mean +/- SD = 5.9 +/- 4.6 years) were enrolled in the study. The HAV seropositivity rate of patients aged <10 years and > or =10 years were 13.1% and 25%, respectively. The seropositivity rate of patients with favorable outcomes (total bilirubin level < or =2 mg/dl) and unfavorable outcome (total bilirubin level >2 mg/dl) were 17.5% and 13.5%, respectively, which were not statistically different (p = 0.6). Children suffering from BA with failed portoenterostomy are at risk of developing severe liver damage at an early age. In these patients a superimposed acute liver infection due to a hepatitis virus, including HAV, may affect liver function and lead to particularly severe disease. The effectiveness of HAV immunization in this particular group of children merits further study.
Related Concept Videos
Hepatitis
Viral Hepatitis I: Introduction
Poliomyelitis
